Ocean Biomedical, Inc.
OCEAPNKHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$118635
P/E Ratio—
52W High$0.015
52W Low$0.00001
Ocean Biomedical, Inc. (OCEA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OCEA · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: Apr 8, 2025EPS Actual
$0.02
Revenue
—
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Apr 8, 2025
After Market Close
✓ 1-Quarter EPS Beat Streak
OCEA reports quarterly as a PNK-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$1.44 | — | — | — | — | — |
| ◌ Q3 FY2026 | Sep 2, 2026 | -$1.44 | — | — | — | — | — |
| ◌ Q1 FY2026 | Feb 25, 2026 | — | — | — | — | — | — |
| — Q2 FY2025 | Apr 8, 2025 | — | $0.02 | — | — | — | — |
| ▲ Q1 FY2025 | Jan 13, 2025 | -$0.23 | -$0.20 | +13.0% | — | — | — |
| ▼ Q4 FY2024 | Dec 23, 2024 | -$0.19 | -$0.63 | -231.6% | — | — | — |
| ▼ Q3 FY2024 | Sep 27, 2024 | -$0.22 | -$0.63 | -185.0% | — | — | — |
| ▼ Q2 FY2024 | Apr 15, 2024 | -$0.15 | -$0.53 | -253.3% | — | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$1.44
EPS Surpr.
—
Revenue
—
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$1.44
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 25, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 8, 2025
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Jan 13, 2025Beat
EPS Actual
-$0.20
EPS Est.
-$0.23
EPS Surpr.
+13.0%
Revenue
—
Q4 FY2024
Dec 23, 2024Miss
EPS Actual
-$0.63
EPS Est.
-$0.19
EPS Surpr.
-231.6%
Revenue
—
Q3 FY2024
Sep 27, 2024Miss
EPS Actual
-$0.63
EPS Est.
-$0.22
EPS Surpr.
-185.0%
Revenue
—
Q2 FY2024
Apr 15, 2024Miss
EPS Actual
-$0.53
EPS Est.
-$0.15
EPS Surpr.
-253.3%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $-0.24 | $-0.24 | $-0.24 | 1 |
| Q4 FY2027 | $-0.23 | $-0.23 | $-0.23 | 1 |
| Q3 FY2027 | $-0.22 | $-0.22 | $-0.22 | 1 |
| Q2 FY2027 | $-0.20 | $-0.20 | $-0.20 | 1 |
| Q1 FY2027 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Q4 FY2026 | $-0.15 | $-0.15 | $-0.15 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | Apr 8, 2025 | — | $0.04 | $0.04 | -11.86% |
| ▲ Q1 FY2025 | Jan 13, 2025 | +13.0% | $0.63 | $0.68 | +8.21% |
| ▼ Q4 FY2024 | Dec 23, 2024 | -231.6% | $0.66 | $0.64 | -3.61% |
| ▼ Q3 FY2024 | Sep 27, 2024 | -185.0% | $0.93 | $0.96 | +2.88% |
| ▼ Q2 FY2024 | Apr 15, 2024 | -253.3% | $2.24 | $1.90 | -15.18% |
| ▼ Q3 FY2023 | Sep 29, 2023 | -253.0% | $4.27 | $3.90 | -8.67% |
| ▼ Q3 FY2023 | Aug 14, 2023 | -95.0% | $4.36 | $4.57 | +4.82% |
| ▲ Q2 FY2023 | May 1, 2023 | +368.8% | $6.78 | $6.51 | -3.98% |
Q2 FY2025-11.86%
Report Date
Apr 8, 2025
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.04
Q1 FY2025+8.21%
Report Date
Jan 13, 2025
EPS Beat/Miss
+13.0%
Price Before
$0.63
Price After
$0.68
Q4 FY2024-3.61%
Report Date
Dec 23, 2024
EPS Beat/Miss
-231.6%
Price Before
$0.66
Price After
$0.64
Q3 FY2024+2.88%
Report Date
Sep 27, 2024
EPS Beat/Miss
-185.0%
Price Before
$0.93
Price After
$0.96
Q2 FY2024-15.18%
Report Date
Apr 15, 2024
EPS Beat/Miss
-253.3%
Price Before
$2.24
Price After
$1.90
Q3 FY2023-8.67%
Report Date
Sep 29, 2023
EPS Beat/Miss
-253.0%
Price Before
$4.27
Price After
$3.90
Q3 FY2023+4.82%
Report Date
Aug 14, 2023
EPS Beat/Miss
-95.0%
Price Before
$4.36
Price After
$4.57
Q2 FY2023-3.98%
Report Date
May 1, 2023
EPS Beat/Miss
+368.8%
Price Before
$6.78
Price After
$6.51
Avg Beat Reaction+2.12%
Avg Miss Reaction-3.95%
Beat Rate2 / 8 quarters
Largest Move-15.18% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OCEA ends December
Ocean Biomedical, Inc. (OCEA) most recently reported earnings on April 8, 2025 for Q2 FY2025, posting EPS of $0.02 (in line with the analyst consensus of —). The next OCEA earnings date is expected around September 1, 2026.
Each quarter, investors track OCEA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OCEA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OCEA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OCEA earnings · 4 questionsOcean Biomedical, Inc.'s next earnings report is expected around September 1, 2026. OCEA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OCEA historically reports after market close (AMC).
OCEA earnings datewhen is OCEA earningsOCEA next earnings datewhen does OCEA report earningsOCEA earnings calendar
▸ Source: FMP · Ocean Biomedical, Inc. SEC filings · US GAAP · Ocean Biomedical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026